0001104659-23-105910.txt : 20231002
0001104659-23-105910.hdr.sgml : 20231002
20231002162430
ACCESSION NUMBER: 0001104659-23-105910
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231001
FILED AS OF DATE: 20231002
DATE AS OF CHANGE: 20231002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fahey Sandell Jacquelyn
CENTRAL INDEX KEY: 0001984647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37625
FILM NUMBER: 231300015
MAIL ADDRESS:
STREET 1: C/O VOYAGER THERAPEUTICS, INC.
STREET 2: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Voyager Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640266
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-5340
MAIL ADDRESS:
STREET 1: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
tm2327331-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-01
0
0001640266
Voyager Therapeutics, Inc.
VYGR
0001984647
Fahey Sandell Jacquelyn
C/O VOYAGER THERAPEUTICS, INC.
64 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Legal Officer
0
Common Stock
2023-10-01
4
A
0
61000
0
A
61000
D
This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
Consists of shares of common stock underlying a restricted stock unit ("RSU") award. Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is October 1, 2023. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting upon the one-year anniversary of such vesting commencement date and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued service as an employee.
/s/ Jacquelyn Fahey Sandell
2023-10-02